People | June 29, 2022
DTx Pharma appoints Peter Condon as Chief Business Officer
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation
An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching
The facility is among 12 centres established worldwide, and the first in Asia
Subscribe To Our Newsletter & Stay Updated
